Levothyroxine sodium and Pelvic inflammatory disease - a phase IV clinical study of FDA data

Summary:

Pelvic inflammatory disease is found among people who take Levothyroxine sodium, especially for people who are 40-49 old.

The phase IV clinical study analyzes which people take Levothyroxine sodium and have Pelvic inflammatory disease. It is created by eHealthMe based on reports of 104,786 people who have side effects when taking Levothyroxine sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

104,786 people reported to have side effects when taking Levothyroxine sodium.
Among them, 13 people (0.01%) have Pelvic inflammatory disease.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 111,499 Levothyroxine sodium users for its effectiveness, alternative drugs and more.

What is Pelvic inflammatory disease?

Pelvic inflammatory disease is found to be associated with 510 drugs and 267 conditions by eHealthMe.

Number of Levothyroxine sodium and Pelvic inflammatory disease reports submitted per year:

Could Levothyroxine sodium cause Pelvic inflammatory disease?

Age of people who have Pelvic inflammatory disease when taking Levothyroxine sodium *:

Common drugs people take besides Levothyroxine sodium *:

Neurontin: 4 people, 30.77%
Diltiazem Hydrochloride: 4 people, 30.77%
Fluticasone Propionate: 4 people, 30.77%
Lamotrigine: 4 people, 30.77%
Lansoprazole: 4 people, 30.77%
Bupropion Hydrochloride: 4 people, 30.77%
Lithium Carbonate: 4 people, 30.77%
Methotrexate: 4 people, 30.77%
Celebrex: 4 people, 30.77%
Metoprolol Succinate: 4 people, 30.77%

Common side effects people have besides Pelvic inflammatory disease *:

Weight Increased: 5 people, 38.46%
Stress And Anxiety: 5 people, 38.46%
Back Pain: 5 people, 38.46%
Fall: 5 people, 38.46%
Fatigue (feeling of tiredness): 5 people, 38.46%
Fever: 5 people, 38.46%
Headache (pain in head): 5 people, 38.46%
Loss Of Consciousness: 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Ovarian Cysts (fluid filled sacs of the ovary): 5 people, 38.46%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
Bipolar Disorder (mood disorder): 4 people, 30.77%
Birth Control: 3 people, 23.08%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 15.38%
Pain: 2 people, 15.38%
Ovulation Induction: 1 person, 7.69%
Blood Luteinising Hormone Decreased: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and have Pelvic inflammatory disease?

Check whether Pelvic inflammatory disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Levothyroxine sodium side effects:

Fatigue (feeling of tiredness): 8,048 reports
Weakness: 5,665 reports
Diarrhea: 5,664 reports
Breathing difficulty: 5,310 reports
Headache (pain in head): 5,293 reports
Drug ineffective: 5,118 reports
Dizziness: 5,079 reports

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pelvic inflammatory disease treatments and more:

Pelvic inflammatory disease (2,016 reports)

COVID vaccines that are related to Pelvic inflammatory disease:

Common drugs associated with Pelvic inflammatory disease:

Mirena: 730 reports
Doxycycline: 108 reports

All the drugs that are associated with Pelvic inflammatory disease:

Pelvic inflammatory disease (510 drugs)

Common conditions associated with Pelvic inflammatory disease:

Birth control: 686 reports

All the conditions that are associated with Pelvic inflammatory disease:

Pelvic inflammatory disease (267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothyroxine sodium) and Levothyroxine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.